Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Genentech limits Avastin distribution

Effective Nov. 30, compounding pharmacies will no longer be allowed to purchase Avastin bevacizumab in an effort to stop

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE